STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Immuron Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Immuron Limited furnished a Form 6-K announcing that it has attached an Australian Securities Exchange notice titled “Proposed issue of securities - IMC.” The filing provides the ASX public notice as Exhibit 99.1 for U.S. investors’ awareness.

The submission is an information update and does not include financial results or transaction terms. It primarily serves to make the ASX announcement available to the U.S. market.

Positive
  • None.
Negative
  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of November 2025

 

Commission File Number: 001-38104

 

IMMURON LIMITED

(Name of Registrant)

 

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ☐       No ☒

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 

 

 

 

IMMURON LIMITED

 

EXPLANATORY NOTE

 

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on November 6, 2025 titled:

 

  - Proposed issue of securities - IMC
  -  

 

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

 

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

1

 

 

EXHIBITS

 

Exhibit
Number
  Description
99.1   Proposed issue of securities - IMC

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  IMMURON LIMITED
     
Date: November 6, 2025 By: /s/ Phillip Hains
    Phillip Hains
    Company Secretary

 

 

3

 

 

FAQ

What did Immuron (IMRN) disclose in this Form 6-K?

The company furnished an ASX announcement titled “Proposed issue of securities - IMC” as an exhibit.

What is attached to the Immuron (IMRN) 6-K?

Exhibit 99.1, which is the ASX notice “Proposed issue of securities - IMC.”

When was the ASX announcement referenced by Immuron (IMRN) made?

November 6, 2025.

Does the 6-K contain financial results for Immuron (IMRN)?

No. It furnishes the ASX notice and does not present earnings or financial tables.

Is the Immuron (IMRN) 6-K incorporated by reference into other filings?

It states it is not deemed filed or incorporated by reference unless specifically referenced.

What is the exhibit number in the Immuron (IMRN) 6-K?

Exhibit 99.1.
Immuron Ltd

NASDAQ:IMRN

IMRN Rankings

IMRN Latest News

IMRN Latest SEC Filings

IMRN Stock Data

10.84M
6.95M
0.34%
1.04%
Biotechnology
Healthcare
Link
Australia
Carlton